IRIS Accounts Production v24.3.2.46 12550383 director 1.5.23 30.4.24 30.4.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh125503832023-04-30125503832024-04-30125503832023-05-012024-04-30125503832022-04-30125503832022-05-012023-04-30125503832023-04-3012550383ns15:EnglandWales2023-05-012024-04-3012550383ns14:PoundSterling2023-05-012024-04-3012550383ns10:Director12023-05-012024-04-3012550383ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3012550383ns10:SmallEntities2023-05-012024-04-3012550383ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3012550383ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3012550383ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3012550383ns10:FullAccounts2023-05-012024-04-3012550383ns10:RegisteredOffice2023-05-012024-04-3012550383ns5:CurrentFinancialInstruments2024-04-3012550383ns5:CurrentFinancialInstruments2023-04-3012550383ns5:ShareCapital2024-04-3012550383ns5:ShareCapital2023-04-3012550383ns5:RetainedEarningsAccumulatedLosses2024-04-3012550383ns5:RetainedEarningsAccumulatedLosses2023-04-3012550383ns5:PlantMachinery2023-05-012024-04-3012550383ns5:PlantMachinery2023-04-3012550383ns5:PlantMachinery2024-04-3012550383ns5:PlantMachinery2023-04-3012550383ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3012550383ns5:WithinOneYearns5:CurrentFinancialInstruments2023-04-3012550383ns5:DeferredTaxation2023-04-3012550383ns5:DeferredTaxation2023-05-012024-04-3012550383ns5:DeferredTaxation2024-04-30
REGISTERED NUMBER: 12550383 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 APRIL 2024

FOR

KANE MEDICAL LIMITED

KANE MEDICAL LIMITED (REGISTERED NUMBER: 12550383)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


KANE MEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 APRIL 2024







DIRECTOR: Mr T P Kane





REGISTERED OFFICE: Larch House
Parklands Business Park
Denmead
Hampshire
PO7 6XP





REGISTERED NUMBER: 12550383 (England and Wales)





ACCOUNTANTS: Gibson Whitter
Chartered Accountants
and Chartered Tax Advisers
Larch House
Parklands Business Park
Denmead
Hampshire
PO7 6XP

KANE MEDICAL LIMITED (REGISTERED NUMBER: 12550383)

BALANCE SHEET
30 APRIL 2024

30.4.24 30.4.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 10,448 11,748

CURRENT ASSETS
Debtors 5 17,912 16,369
Cash at bank 212,017 132,138
229,929 148,507
CREDITORS
Amounts falling due within one year 6 28,788 17,959
NET CURRENT ASSETS 201,141 130,548
TOTAL ASSETS LESS CURRENT
LIABILITIES

211,589

142,296

PROVISIONS FOR LIABILITIES 7 2,612 2,937
NET ASSETS 208,977 139,359

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 208,877 139,259
208,977 139,359

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved and authorised for issue by the director and authorised for issue on 21 January 2025 and were signed by:




Mr T P Kane - Director


KANE MEDICAL LIMITED (REGISTERED NUMBER: 12550383)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

1. STATUTORY INFORMATION

Kane Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost and 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

KANE MEDICAL LIMITED (REGISTERED NUMBER: 12550383)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 May 2023 14,055
Additions 1,251
At 30 April 2024 15,306
DEPRECIATION
At 1 May 2023 2,307
Charge for year 2,551
At 30 April 2024 4,858
NET BOOK VALUE
At 30 April 2024 10,448
At 30 April 2023 11,748

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£    £   
Trade debtors 17,266 6,755
Other debtors 646 9,614
17,912 16,369

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£    £   
Trade creditors 2,444 326
Taxation and social security 20,423 14,482
Other creditors 5,921 3,151
28,788 17,959

7. PROVISIONS FOR LIABILITIES
30.4.24 30.4.23
£    £   
Deferred tax 2,612 2,937

Deferred
tax
£   
Balance at 1 May 2023 2,937
Utilised during year (325 )
Balance at 30 April 2024 2,612

KANE MEDICAL LIMITED (REGISTERED NUMBER: 12550383)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024

8. RELATED PARTY DISCLOSURES

The aggregate amount owed by the connected companies at the balance sheet date was £NIL (30.4.23: £255).

The aggregate amount owed to the director at the balance sheet date is £4,661 (30.4.23: owed by £8,672).

9. ULTIMATE CONTROLLING PARTY

The company is not under control of any one individual or another entity.